Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis ALKEM

Max Ratio

5.31

Dividend Yield

0.97 %

5Y Dividend Growth

181.00 %

Consecutive Years

7 years

5Y Average Payout Ratio

29.27 %

Dividend History ALKEM

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.97 %
Consecutive Years 7
Forward Annual Dividend 55.00 INR
Consistent Years 7
Dividend CAGR 3Y 14.47 %
Continuous Dividends
Dividend CAGR 5Y 22.98 %
Payout Ratio TTM 11.39 %
Dividend CAGR 10Y
Ex Dividend Date 08/08/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth ALKEM

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin ALKEM

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income ALKEM

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM ALKEM

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio ALKEM

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Alkem Laboratories Limited ALKEM

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself ALKEM

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 28.63
Forward PE 33.78
Enterprise Value Revenue 4.71
Price Sales TTM 4.87
Enterprise Value EBITDA 19.77
Price Book MRQ 5.05

Alkem Laboratories Limited Dividends: 0.80 % Yield, History, Payment Schedule

ALKEM
Current price
5 659.00 INR -9.97 INR (-0.18%)
Last closed 5 647.50 INR
ISIN INE540L01014
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange National Stock Exchange of India
Capitalization 677 754 402 182 INR
Yield for 12 month +0.27 %
1Y
3Y
5Y
10Y
15Y
ALKEM
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+129 862 884 737 INR

Last Year

+125 884 015 057 INR

Current Quarter

+40 077 079 817 INR

Last Quarter

+33 768 004 164 INR

Current Year

+80 525 482 143 INR

Last Year

+46 464 386 634 INR

Current Quarter

+26 043 255 468 INR

Last Quarter

+22 036 739 440 INR
EBITDA 27 648 446 364 INR
Operating Margin TTM 20.67 %
Price to Earnings 28.63
Return On Assets TTM 8.11 %
PEG Ratio
Return On Equity TTM 18.74 %
Wall Street Target Price 532 536.02 INR
Revenue TTM 139 134 829 291 INR
Book Value 1 118.14 INR
Revenue Per Share TTM
Dividend Share 8.01 INR
Quarterly Revenue Growth YOY 17.20 %
Dividend Yield 0.97 %
Gross Profit TTM 86 877 126 648 INR
Earnings per share 197.99 INR
Diluted Eps TTM 197.99 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 11.10 %
Profit Margin 17.00 %

Technical Indicators ALKEM

For 52 Weeks

4 491.80 INR 5 877.85 INR
50 Day MA 5 595.63 INR
Shares Short Prior Month
200 Day MA 5 167.87 INR
Short Ratio
Shares Short
Short Percent